Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Tolerability”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02532985
What this trial is testing

Gastrointestinal Tolerability Following Multiple Servings of a Novel Dietary Fiber

Who this might be right for
Signs and Symptoms, Digestive
Cargill 45
Early research (Phase 1)Study completedNCT01708889
What this trial is testing

Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction

Who this might be right for
Chronic Hepatitis B Virus InfectionChronic Hepatitis C Virus Infection
Bristol-Myers Squibb 43
Early research (Phase 1)Study completedNCT00781976
What this trial is testing

Antiviral Activity of AZD7295 in HCV Carriers

Who this might be right for
Hepatitis C
Arrow Therapeutics 31
Testing effectiveness (Phase 2)Ended earlyNCT04821310
What this trial is testing

Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years

Who this might be right for
Esophagitis
Pfizer 43
Early research (Phase 1)Study completedNCT02528799
What this trial is testing

Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease

Who this might be right for
Celiac Disease
ImmusanT, Inc. 38
Testing effectiveness (Phase 2)Study completedNCT01435044
What this trial is testing

Safety Study of Regimens of Sofosbuvir, GS-0938, and Ribavirin in Patients With Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 239
Early research (Phase 1)Study completedNCT06131398
What this trial is testing

AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Amgen 77
Testing effectiveness (Phase 2)Looking for participantsNCT06799637
What this trial is testing

Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments

Who this might be right for
Advanced Solid TumorsPancreatic CarcinomaOvarian Cancer+1 more
Evopoint Biosciences Inc. 350
Testing effectiveness (Phase 2)Study completedNCT01188772
What this trial is testing

Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Patients

Who this might be right for
Hepatitis C Virus
Gilead Sciences 147
Testing effectiveness (Phase 2)Study completedNCT00506792
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QAU145 in Patients With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Novartis Pharmaceuticals 9
Early research (Phase 1)Study completedNCT00387387
What this trial is testing

Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin)

Who this might be right for
Neoplasms, Colorectal
GlaxoSmithKline 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06151964
What this trial is testing

A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight

Who this might be right for
Overweight and Obesity
AstraZeneca 166
Early research (Phase 1)Looking for participantsNCT07517198
What this trial is testing

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

Who this might be right for
Solid TumorSmall Cell Lung Cancer (SCLC)High Grade Neuroendocrine Cancer+9 more
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 40
Testing effectiveness (Phase 2)Ended earlyNCT02193867
What this trial is testing

Clinical Study In Infants With Rapidly Progressive Lysosomal Acid Lipase Deficiency

Who this might be right for
Lysosomal Acid Lipase Deficiency
Alexion Pharmaceuticals, Inc. 10
Early research (Phase 1)UnknownNCT02453464
What this trial is testing

A Phase Ib Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection Plus FOLFIRI in Chinese Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd. 36
Early research (Phase 1)UnknownNCT06280534
What this trial is testing

Safety, Tolerability Phase Ia Study of XT1061 in Single and Multiple Doses in Healthy Subjects

Who this might be right for
Chronic Hepatitis b
Xi'an Xintong Pharmaceutical Research Co.,Ltd. 128
Early research (Phase 1)Active Not RecruitingNCT04511871
What this trial is testing

A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors

Who this might be right for
Solid TumorGastric CancerBreast Cancer+2 more
Shanghai PerHum Therapeutics Co., Ltd. 12
Early research (Phase 1)Looking for participantsNCT07389044
What this trial is testing

A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B Virus Infection
IntegerBio 88
Early research (Phase 1)Ended earlyNCT03189030
What this trial is testing

Study of Personalized Immunotherapy in Adults With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Aduro Biotech, Inc. 28
Testing effectiveness (Phase 2)Ended earlyNCT03893565
What this trial is testing

Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
GlaxoSmithKline 104
Next Page